Section

Medicine

Clinical care, research, FDA

yahoo.com

Rising Use of Banned Peptides Among Bodybuilders Raises Health Concerns

The use of banned peptides among bodybuilders is increasing, with individuals injecting substances like GHK-Cu and Retatrutide for perceived benefits. Experts warn of serious health risks due to a lack of evidence supporting these claims and the absence of safety guidelines. Recent discussions in the U.S. about loosening restrictions on peptides have raised concerns among medical professionals.

Bias: 33 Sentiment: -0.20
Axios

Study finds AI can improve efficiency in clinical trials for cancer treatments

A Tufts Center study reveals that AI can significantly improve the efficiency of clinical trials for cancer treatments, potentially reducing trial time by 10 weeks and costs by up to $5.6 million. The technology may become standard in trials within three to five years, although challenges in patient recruitment and consent persist.

Bias: 4 Sentiment: +0.10
Fox News — Politics

Fauci Discusses COVID-19 mRNA Vaccine Concerns for Pregnant Women in Released Texts

Dr. Anthony Fauci discussed concerns about COVID-19 mRNA vaccines for pregnant women in January 2021, as revealed in text messages released by a Senate committee. The conversations included discussions on potential risks associated with vaccination timing and symptoms after the second dose, as well as the need to balance vaccination risks with COVID-19 risks.

Bias: 4 Sentiment: +0.00
NPR — Top Stories

Medical Bias Affects Treatment for Addiction Patients

Jean Descamps, a 26-year-old man, died shortly after being discharged from Providence Milwaukie Hospital in December 2023. Reports highlight that addiction treatments, while safe and effective, are not commonly offered due to prevailing biases among healthcare professionals against patients with substance use disorders.

Bias: 4 Sentiment: -0.20
The Daily Beast

Study Suggests GLP-1 Medications May Lower Risk of Age-Related Macular Degeneration

A study suggests that GLP-1 medications may lower the risk of age-related macular degeneration in older adults with obesity. The research indicates an 18% reduced risk for those taking GLP-1 drugs compared to other weight-loss medications, with the benefit potentially increasing to 30%. Further studies are needed to clarify the relationship between the medications and eye health.

Bias: 4 Sentiment: +0.10
Vox

GLP-1 Drugs and the Stigma Surrounding Their Use

GLP-1 drugs are designed to treat obesity, but users often face stigma and judgment from society. Research shows that individuals who lose weight with these medications are perceived more negatively than those who lose weight through traditional methods. As GLP-1 usage increases, experts suggest that societal attitudes may evolve, potentially reducing the stigma surrounding their use.

Bias: 16 Sentiment: -0.20
Fox News — Latest

Jillian Michaels warns against dangers of unregulated weight loss drugs

Jillian Michaels has warned against the dangers of self-dosing unregulated weight-loss peptides, citing severe health risks associated with these products. The FDA has issued warnings regarding illegal sales and misleading marketing of GLP-1 compounds, emphasizing the importance of medical supervision for weight-loss treatments. Michaels cautioned that the trend is driven by individuals seeking quick weight loss, often influenced by unrealistic body standards.

Bias: 33 Sentiment: -0.10
studyfinds.com

Study Finds Increased Dementia Risk for Spouses of Affected Individuals

A recent study published in JAMA Network Open reveals that spouses of individuals diagnosed with dementia face a significantly higher risk of developing the condition themselves, with an increase of about 70%. The research highlights the importance of considering the health of both partners in the context of dementia, suggesting that families may benefit from closer monitoring and support.

Bias: 30 Sentiment: +0.00
Ars Technica

The Role of AI in Prior Authorization Processes

Prior authorization is a necessary process for obtaining approval from health insurers for medical treatments, but it can lead to delays that affect patient care. A 2025 survey indicated that many physicians are concerned that the introduction of AI in this process may worsen denial rates for necessary treatments, despite its potential to expedite approvals for clear cases.

Bias: 4 Sentiment: +0.00
The Daily Beast

54-Year-Old Woman Hospitalized After GLP-1 Medication Overdose

Leslie Gammon, a 54-year-old woman from North Carolina, was hospitalized due to an overdose of a GLP-1 medication prescribed through a telehealth service. After experiencing severe side effects, she spent three days in the hospital and has since stopped using the medication. Gammon is now seeking clarification from the telehealth company regarding her hospital expenses.

Bias: 4 Sentiment: -0.20